Items where authors include "Hudson, E"

Article

Holch, P, Absolom, KL orcid.org/0000-0002-5477-6643, Henry, AM orcid.org/0000-0002-5379-6618 et al. (18 more authors) (2023) Online symptom monitoring during pelvic radiotherapy: randomised pilot trial of eRAPID intervention. International Journal of Radiation: Oncology - Biology - Physics, 115 (3). pp. 664-676. ISSN 0360-3016

Velikova, G orcid.org/0000-0003-1899-5942, Absolom, K orcid.org/0000-0002-5477-6643, Hewison, J orcid.org/0000-0003-3026-3250 et al. (20 more authors) (2022) Electronic self-reporting of adverse events for patients undergoing cancer treatment: the eRAPID research programme including two RCTs. Programme Grants for Applied Research, 10 (1). pp. 1-110. ISSN 2050-4322

Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L orcid.org/0000-0002-8389-6134, Hudson, E orcid.org/0000-0001-8758-7163 et al. (6 more authors) (2021) Reply to H. Shojima et al. Journal of Clinical Oncology, 39 (23). pp. 2633-2634. ISSN 0732-183X

Slevin, F orcid.org/0000-0002-7176-904X, Beasley, M, Zhong, J et al. (5 more authors) (2021) A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative Radiotherapy. BJR open, 3 (1). 20210045. p. 20210045. ISSN 2513-9878

Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L orcid.org/0000-0002-8389-6134, Hudson, E orcid.org/0000-0001-8758-7163 et al. (17 more authors) (2021) Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology, 39 (7). pp. 734-747. ISSN 0732-183X

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2018) Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 167 (1). p. 407. ISSN 0167-6806

Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806

Clarke, BG orcid.org/0000-0001-9493-9200, Barrett, B, Hudson, E et al. (1 more author) (2017) Engineering the landscape – Capability Brown’s role. Proceedings of the Institution of Civil Engineers (London) Engineering History and Heritage, 170 (1). pp. 19-30. ISSN 1757-9430

Conference or Workshop Item

Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L, Woroncow, B et al. (5 more authors) (2022) eRAPID: INSIGHTS UnderstandIng, iNterpreting and SharInG patient reported data: Further in-deptH analysis and visualisaTion of cancer Symptom profiles from the eRAPID programme. In: British Psychosocial Oncology Society 2022 Conference, Equality, Diversity and Inclusion in Psychosocial Oncology, 28-29 Apr 2022, Online.

Velikova, G, Dawkins, B orcid.org/0000-0002-7038-1975, Absolom, K orcid.org/0000-0002-5477-6643 et al. (9 more authors) (2021) Cost effectiveness of eRAPID eHealth intervention for symptom management during chemotherapy. In: NCRI Cancer Conference 2021.

Slevin, F, Beasley, M, Zhong, J et al. (5 more authors) (2021) A feasibility trial of buscopan to improve cone beam CT image quality during abdominal/pelvic SABR. In: ESTRO 2021, 28-21 Aug 2021, Madrid, Spain.

Velikova, G orcid.org/0000-0003-1899-5942, Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L et al. (11 more authors) (2020) Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)-An eHealth intervention during chemotherapy. In: 27th Annual Conference of the International Society for Quality of Life Research, 19-23 Oct 2020, Online.

Holch, PT, Absolom, K, Gibson, A et al. (13 more authors) (2020) A pilot randomized trial of online self-monitoring of adverse events during pelvic radiotherapy using eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice). In: 27th Annual Conference of the International Society for Quality of Life Research, 17 Oct 2020, Online.

Velikova, G orcid.org/0000-0003-1899-5942, Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L et al. (8 more authors) (2020) Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)—An eHealth intervention during chemotherapy. In: 2020 ASCO Annual Meeting I, 29 May - 01 Jun 2020, Online.

Absolom, K orcid.org/0000-0002-5477-6643, Warrington, L, Holch, P et al. (9 more authors) (2020) Preliminary data from a randomised trial of online self-monitoring of adverse events during systemic therapy using eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice). In: British Psychosocial Oncology Society Annual Conference, 27-28 Feb 2020, Edinburgh.